Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FC6G5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $85,996
Award facts
- Contract value 100% obligated
- $85,995.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a firm fixed price contract value of $85,995.90 and an ultimate completion date of June 3, 2025. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
This IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Through this contract vehicle, AmerisourceBergen serves customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm's consistent receipt of competitively awarded delivery orders across various therapeutic categories demonstrates its capability to meet federal procurement requirements and its significant role in supporting the Defense Logistics Agency's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FC6G5?
SPE2DB25FC6G5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FC6G5 worth?
The government has obligated $85,996 on SPE2DB25FC6G5.
Is contract SPE2DB25FC6G5 an order under another contract?
Yes. SPE2DB25FC6G5 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC6G5 competed?
The extent of competition for SPE2DB25FC6G5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award